Brief: Cerenis Therapeutics Holding H1 Net Loss Widens To EUR 3.4 Million
Sept 10 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
CEREN.PA :
* H1 NET LOSS EUR 3.4 MILLION VERSUS LOSS EUR 0.7 MILLION
YEAR
AGO
Source text for Eikon: ID:nBw1h91V4a
See also: urn:newsml:reuters.com:*:nL5N1VW0EE
Further company coverage: CEREN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Abionyx Pharma SA
See all newsBrief: ABIONYX Pharma And OLON Enter Into Strategic Manufacturing Partnership
France's ABIONYX Pharma H1 net loss widens as financial expenses rise
Brief: ABIONYX Pharma H1 EBIT EUR -2.27 Million
Abionyx jumps as Stifel starts coverage with 'buy'
Cardiovascular drug developer ABIONYX Pharma's H1 revenue falls